STOCK TITAN
  1. Home
  2. Financials
  3. XFOR
  4. EPS (Diluted)

X4 Pharmaceuticals (XFOR) EPS by Year

XFOR NASDAQ

X4 Pharmaceuticals, Inc. lost $1.87 per diluted share in fiscal year 2025. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters X4 Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.87
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XFOR EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
EPS (Diluted)-$1.87-$5.59n/m-$17.07-$1.52-$3.99n/m-$3.09-$4.63-$79.15n/m-$54.58n/m-$44.79

XFOR EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.13-$0.16N/A-$0.69-$3.47-125.6%$0.04-$5.94n/m-$5.48$13.57-$7.77-$0.09n/m-$0.01

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More X4 Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was X4 Pharmaceuticals, Inc.'s diluted earnings per share in fiscal year 2025?

X4 Pharmaceuticals, Inc. lost $1.87 per diluted share in fiscal year 2025.

How has X4 Pharmaceuticals, Inc.'s diluted earnings per share changed over the years?

Across the 10 fiscal years this page covers, X4 Pharmaceuticals, Inc. (XFOR) diluted earnings per share went from -$44.79 in fiscal year 2016 to -$1.87 in fiscal year 2025.

What was X4 Pharmaceuticals, Inc.'s diluted earnings per share in the most recent quarter?

X4 Pharmaceuticals, Inc. (XFOR) reported -$0.13 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what X4 Pharmaceuticals, Inc. (XFOR) reported on that line in every period on record.